Review of current clinical strategies of managing patients with elevated lipoprotein (a): cost-effectiveness of Lp (a) testing and patient awareness of lifestyle changes … J Adams, P Orfanos, X Hu, G Montgomery, C Abbas, L Lymperopoulou, ... Heart, Lung and Circulation 33, S534 , 2024 2024 Citations: 2
The Risk of MACE Associated With Elevated Lp (a) in a Primary Prevention Population J Adams, H Benbow, A Al Zabiby, H Byrne, M Costa-Scharplatz Heart, Lung and Circulation 33, S541 , 2024 2024
Elevated lipoprotein (a) increases risk of subsequent major adverse cardiovascular events (MACE) and coronary revascularisation in incident ASCVD patients: a cohort study from … P Welsh, A Al Zabiby, H Byrne, HR Benbow, T Itani, G Farries, ... Atherosclerosis 389, 117437 , 2024 2024 Citations: 31
EPH58 The Risk of First and Recurrent Mace Associated with Elevated Lp (A) in a Primary Prevention Population H Benbow, A Al Zabiby, H Byrne, M Costa Value in Health 26 (12), S213 , 2023 2023
Increased Risk of Major Adverse Cardiovascular Events Attributed to Lipoprotein (a) Across Current Atherosclerotic Cardiovascular Disease Risk Categories H Benbow, A Al Zabiby, X Hu, H Byrne, M Costa-Scharplatz Circulation 148 (Suppl_1), A14601-A14601 , 2023 2023
Review on clinical strategies for managing patients with elevated Lp (a): cost-effectiveness of Lp (a) testing and awareness of lifestyle changes via public health policy in … P Orfanos, X Hu, G Montgomery, C Abbas, L Lymperopoulou, N Bennett, ... European Journal of Cardiovascular Nursing 22 (Supplement_1), zvad064. 121 , 2023 2023 Citations: 4
The burden of coronary revascularization associated with lipoprotein(a) in patients with atherosclerotic cardiovascular disease: data from the UK Biobank NS P Welsh, H Byrne, M Costa-Scharplatz, A F Fonseca, T Itani, G Farries, A ... European Heart Journal 43 (Issue Supplement_2) , 2022 2022
The association of lipoprotein(a) with mace including coronary revascularisations in patients with atherosclerotic cardiovascular disease: Data from UK Biobank NS P.I. Welsh, R. Brown, A.F. Fonseca, G.Farries, T.Itani, A. Al Zabiby, S ... Atherosclerosis 355, Page 41 , 2022 2022
MOST CITED SCHOLAR PUBLICATIONS
Elevated lipoprotein (a) increases risk of subsequent major adverse cardiovascular events (MACE) and coronary revascularisation in incident ASCVD patients: a cohort study from … P Welsh, A Al Zabiby, H Byrne, HR Benbow, T Itani, G Farries, ... Atherosclerosis 389, 117437 , 2024 2024 Citations: 31
Review on clinical strategies for managing patients with elevated Lp (a): cost-effectiveness of Lp (a) testing and awareness of lifestyle changes via public health policy in … P Orfanos, X Hu, G Montgomery, C Abbas, L Lymperopoulou, N Bennett, ... European Journal of Cardiovascular Nursing 22 (Supplement_1), zvad064. 121 , 2023 2023 Citations: 4
Review of current clinical strategies of managing patients with elevated lipoprotein (a): cost-effectiveness of Lp (a) testing and patient awareness of lifestyle changes … J Adams, P Orfanos, X Hu, G Montgomery, C Abbas, L Lymperopoulou, ... Heart, Lung and Circulation 33, S534 , 2024 2024 Citations: 2
The Risk of MACE Associated With Elevated Lp (a) in a Primary Prevention Population J Adams, H Benbow, A Al Zabiby, H Byrne, M Costa-Scharplatz Heart, Lung and Circulation 33, S541 , 2024 2024
EPH58 The Risk of First and Recurrent Mace Associated with Elevated Lp (A) in a Primary Prevention Population H Benbow, A Al Zabiby, H Byrne, M Costa Value in Health 26 (12), S213 , 2023 2023
Increased Risk of Major Adverse Cardiovascular Events Attributed to Lipoprotein (a) Across Current Atherosclerotic Cardiovascular Disease Risk Categories H Benbow, A Al Zabiby, X Hu, H Byrne, M Costa-Scharplatz Circulation 148 (Suppl_1), A14601-A14601 , 2023 2023
The burden of coronary revascularization associated with lipoprotein(a) in patients with atherosclerotic cardiovascular disease: data from the UK Biobank NS P Welsh, H Byrne, M Costa-Scharplatz, A F Fonseca, T Itani, G Farries, A ... European Heart Journal 43 (Issue Supplement_2) , 2022 2022
The association of lipoprotein(a) with mace including coronary revascularisations in patients with atherosclerotic cardiovascular disease: Data from UK Biobank NS P.I. Welsh, R. Brown, A.F. Fonseca, G.Farries, T.Itani, A. Al Zabiby, S ... Atherosclerosis 355, Page 41 , 2022 2022
